2019
SY6-1 Cancer immunotherapy; A paradigm shift in the first-line treatment of lung cancer
Herbst R. SY6-1 Cancer immunotherapy; A paradigm shift in the first-line treatment of lung cancer. Annals Of Oncology 2019, 30: vi32. DOI: 10.1093/annonc/mdz325.Peer-Reviewed Original ResearchLung cancerImmune checkpoint inhibitorsFirst-line treatmentMinority of patientsTumor mutational burdenPresence of tumorEfficient trial designMarker of resistanceCheckpoint inhibitorsTreatment of cancerCancer deathCancer immunotherapyPredictive markerSmoking ratesMutational burdenNew therapiesTrial designImmune systemCancerTherapyImmunotherapyChemotherapyPatientsTreatmentMarkers
2015
Electronic Nicotine Delivery Systems: A Policy Statement from the American Association for Cancer Research and the American Society of Clinical Oncology
Brandon TH, Goniewicz ML, Hanna NH, Hatsukami DK, Herbst RS, Hobin JA, Ostroff JS, Shields PG, Toll BA, Tyne CA, Viswanath K, Warren GW. Electronic Nicotine Delivery Systems: A Policy Statement from the American Association for Cancer Research and the American Society of Clinical Oncology. Clinical Cancer Research 2015, 21: 514-525. PMID: 25573384, DOI: 10.1158/1078-0432.ccr-14-2544.Peer-Reviewed Original ResearchConceptsElectronic nicotine delivery systemsTobacco useClinical OncologyHarm-reduction devicesNumber one preventable causeAmerican SocietyCombustible tobacco productsNicotine delivery systemsCancer researchCombustible tobacco useAdverse health effectsAmerican AssociationChildproof capsFormer smokersCigarette smokingPreventable causeSmoking ratesENDS useDefinitive dataE-cigarettesTobacco productsHealth effectsSmokersSmokingHealth impactsElectronic Nicotine Delivery Systems: A Policy Statement From the American Association for Cancer Research and the American Society of Clinical Oncology
Brandon TH, Goniewicz ML, Hanna NH, Hatsukami DK, Herbst RS, Hobin JA, Ostroff JS, Shields PG, Toll BA, Tyne CA, Viswanath K, Warren GW. Electronic Nicotine Delivery Systems: A Policy Statement From the American Association for Cancer Research and the American Society of Clinical Oncology. Journal Of Clinical Oncology 2015, 33: 952-963. PMID: 25572671, DOI: 10.1200/jco.2014.59.4465.Peer-Reviewed Original ResearchConceptsElectronic nicotine delivery systemsClinical OncologyTobacco useAmerican SocietyCancer researchHarm-reduction devicesNumber one preventable causeAmerican AssociationJoint writing groupCombustible tobacco productsClinical cancer researchNicotine delivery systemsCombustible tobacco useAdverse health effectsChildproof capsFormer smokersCigarette smokingPreventable causeTobacco cessationSmoking ratesUS FoodDrug AdministrationENDS useDefinitive dataElectronic cigarettes